[HTML][HTML] Current role of dexmedetomidine in clinical anesthesia and intensive care

M Kaur, PM Singh - Anesthesia Essays and Researches, 2011 - journals.lww.com
Dexmedetomidine is a new generation highly selective α2-adrenergic receptor (α2-AR)
agonist that is associated with sedative and analgesic sparing effects, reduced delirium and …

Current role of dexmedetomidine in clinical anesthesia and intensive care.

M Kaur, PM Singh - Anesthesia, Essays and Researches, 2011 - europepmc.org
Dexmedetomidine is a new generation highly selective α2-adrenergic receptor (α2-AR)
agonist that is associated with sedative and analgesic sparing effects, reduced delirium and …

[PDF][PDF] Current role of dexmedetomidine in clinical anesthesia and intensive care

M Kaur, PM Singh - academia.edu
Dexmedetomidine is a new generation highly selective α2-adrenergic receptor (α2-AR)
agonist that is associated with sedative and analgesic sparing effects, reduced delirium and …

[HTML][HTML] Current role of dexmedetomidine in clinical anesthesia and intensive care

M Kaur, PM Singh - Anesthesia, Essays and Researches, 2011 - ncbi.nlm.nih.gov
Dexmedetomidine is a new generation highly selective α2-adrenergic receptor (α2-AR)
agonist that is associated with sedative and analgesic sparing effects, reduced delirium and …

Current role of dexmedetomidine in clinical anesthesia and intensive care

M Kaur, PM Singh - Anesthesia, essays and researches, 2011 - pubmed.ncbi.nlm.nih.gov
Dexmedetomidine is a new generation highly selective α2-adrenergic receptor (α2-AR)
agonist that is associated with sedative and analgesic sparing effects, reduced delirium and …

Current role of dexmedetomidine in clinical anesthesia and intensive care

M Kaur, P Singh - Anesthesia: Essays and Researches, 2011 - go.gale.com
Dexmedetomidine is a new generation highly selective a 2-adrenergic receptor (a 2-AR)
agonist that is associated with sedative and analgesic sparing effects, reduced delirium and …

Current role of dexmedetomidine in clinical anesthesia and intensive care.

M Kaur, PM Singh - Anesthesia: Essays & Researches, 2011 - search.ebscohost.com
Dexmedetomidine is a new generation highly selective α2-adrenergic receptor (α2-AR)
agonist that is associated with sedative and analgesic sparing effects, reduced delirium and …

Current role of dexmedetomidine in clinical anesthesia and intensive care.

M Kaur, PM Singh - Anesthesia, Essays and Researches, 2011 - europepmc.org
Dexmedetomidine is a new generation highly selective α2-adrenergic receptor (α2-AR)
agonist that is associated with sedative and analgesic sparing effects, reduced delirium and …

[PDF][PDF] Current role of dexmedetomidine in clinical anesthesia and intensive care

M Kaur, PM Singh - academia.edu
Dexmedetomidine is a new generation highly selective α2-adrenergic receptor (α2-AR)
agonist that is associated with sedative and analgesic sparing effects, reduced delirium and …

Current role of dexmedetomidine in clinical anesthesia and intensive care

M Kaur, PM Singh - Anesthesia, essays and researches, 2011 - pubmed.ncbi.nlm.nih.gov
Dexmedetomidine is a new generation highly selective α2-adrenergic receptor (α2-AR)
agonist that is associated with sedative and analgesic sparing effects, reduced delirium and …